Genetic depletion in zebrafish uncovers requirement for septins in haematopoiesis

This study demonstrates that genetic depletion of septins in zebrafish unexpectedly enhances macrophage-mediated protection against mycobacterial infection by driving the overproduction of myeloid-biased haematopoietic stem and progenitor cells, thereby establishing a critical role for septins in regulating haematopoiesis and offering new insights into blood disorders like acute myeloid leukaemia.

The Gist

Imagine your body's immune system as a bustling factory that produces a constant stream of specialized workers called blood cells. Some of these workers are the "generals" (stem cells) who decide what kind of troops to send out next, while others are the "foot soldiers" (like macrophages) that fight off infections.

For a long time, scientists knew that the factory's internal scaffolding—the cytoskeleton—was crucial for keeping the production line running smoothly. However, one specific type of scaffolding protein, called septins, was a bit of a mystery. We knew they helped cells divide and fight germs, but we didn't fully understand their role in making blood cells.

To solve this puzzle, researchers turned to zebrafish, tiny fish that are excellent for studying how bodies grow and heal. They created a special group of zebrafish larvae that were missing these septin proteins, essentially taking the scaffolding out of the factory.

The Big Surprise
The scientists expected these "scaffolding-free" fish to be weaker and more likely to get sick. Instead, they found the exact opposite! When exposed to a specific type of bacteria (Mycobacterium marinum), the septin-deficient fish were actually protected.

Why? Because their bodies had gone into overdrive:

• More Soldiers: They produced a massive surplus of macrophages (the infection-fighting foot soldiers).
• Better Defense: These soldiers were tougher, dying less often, and launching stronger attacks against the bacteria.

The Hidden Cost
Digging deeper, the researchers discovered why the fish had so many more soldiers. Without septins, the factory's "generals" (the stem cells) were producing way too many myeloid cells (the infection fighters).

However, in this factory, resources are limited. It's like a bakery that suddenly decides to bake only bread and no cakes. Because the factory was so focused on churning out myeloid cells, it stopped making red blood cells (the erythroid lineage). The fish had a flood of infection fighters but a shortage of oxygen carriers.

Why This Matters
This discovery is like finding a missing instruction manual for how blood cells are made. The researchers found that when septins are missing, the blood production line gets unbalanced. This mirrors what happens in real human blood disorders, such as:

• Acute Myeloid Leukemia (where the body makes too many immature white blood cells).
• Myelodysplastic Syndrome (where blood cells don't mature correctly).
• Bernard-Soulier Syndrome (a disorder affecting platelets).

The paper concludes that zebrafish are now a powerful new tool for studying how septins control blood production. By understanding this "scaffolding" in fish, we can better understand how similar "scaffolding" issues might cause blood diseases in humans, potentially leading to new ways to treat these conditions.

Technical Summary

Technical Summary: Genetic Depletion in Zebrafish Uncovers Requirement for Septins in Haematopoiesis

Problem Statement
Haematopoiesis and the subsequent differentiation of immune cells from haematopoietic stem and progenitor cells (HSPCs) are fundamental to health and disease. While the cytoskeleton is recognized as a key regulator of cell division and lineage bias during these processes, the specific role of the septin cytoskeleton in haematopoiesis remains largely unknown. Although septins are well-characterized as unconventional filament-forming proteins involved in cell division and host defence, their regulatory mechanisms within the haematopoietic system have not been fully elucidated, particularly in vivo.

Methodology
To investigate the role of septins in host defence and haematopoiesis, the authors generated septin-deficient zebrafish models. These models were utilized to study the interaction with Mycobacterium marinum, a pathogen used to model mycobacterial infection. The study employed genetic depletion of septins to observe phenotypic changes in larvae, specifically monitoring macrophage numbers, cell death rates, inflammatory responses, and the production and lineage bias of HSPCs. The findings were contextualized against classical HSPC hierarchy and compared with known hallmarks of human haematological disorders.

Key Results
Contrary to the expectation that septin deficiency would compromise host defence, the septin-deficient larvae were found to be protected from Mycobacterium marinum infection. This protection was driven by three specific physiological changes:

1. A significant increase in macrophage numbers.
2. Reduced cell death.
3. Enhanced inflammatory responses.

Further investigation revealed that these phenotypes stemmed from a fundamental alteration in haematopoiesis. Septin-deficient larvae produced significantly more HSPCs and exhibited a distinct myeloid lineage bias. Consistent with the classical HSPC hierarchy, this increase in myeloid production occurred at the expense of erythroid lineage production.

Significance and Claims
The paper establishes a previously unknown requirement for septins in the regulation of haematopoiesis. The authors claim that their findings provide a mechanistic link between septin dysfunction and specific human haematological disorders, including acute myeloid leukaemia, myelodysplastic syndrome, and the platelet disorder Bernard-Soulier syndrome.

Furthermore, the study highlights the zebrafish as a novel and effective model for investigating septin-mediated haematopoiesis. The authors suggest that these insights support the potential application of septin-based medicines in the treatment of blood disorders, positioning the zebrafish model as a critical tool for future therapeutic development in this domain.